Preoperative evaluation of stage I and stage II non-small cell lung cancer

Ann Thorac Surg. 1994 Dec;58(6):1738-41. doi: 10.1016/0003-4975(94)91673-x.

Abstract

The appropriate preoperative evaluation for occult metastasis in patients with potentially resectable lung cancer remains controversial. The records of 265 patients with stage I and II non-small cell lung cancers who underwent resection with curative intent were reviewed to determine if there was a survival benefit of negative preoperative scanning to detect metastases. A minimum of 5 years of follow-up was possible for all long-term survivors. Patients having preoperative bone scans, brain imaging, and abdominal imaging had no increased survival over those without such evaluation (using Kaplan-Meier survival curves). Additionally, no difference was found in the time to first recurrence between these groups, and the site of recurrence was independent of a negative preoperative scan for that location. These data, using patient outcome as the basis of our conclusion, support a policy of reserving expensive preoperative metastatic evaluations only for those patients with clinical evidence of metastatic disease.

MeSH terms

  • Abdominal Neoplasms / diagnosis
  • Abdominal Neoplasms / secondary
  • Bone Neoplasms / diagnosis
  • Bone Neoplasms / secondary
  • Brain Neoplasms / diagnosis
  • Brain Neoplasms / secondary
  • Carcinoma, Non-Small-Cell Lung / diagnosis
  • Carcinoma, Non-Small-Cell Lung / mortality
  • Carcinoma, Non-Small-Cell Lung / secondary*
  • Carcinoma, Non-Small-Cell Lung / surgery*
  • Female
  • Humans
  • Lung Neoplasms / mortality
  • Lung Neoplasms / pathology
  • Lung Neoplasms / surgery*
  • Male
  • Neoplasm Staging
  • Preoperative Care*
  • Radionuclide Imaging / statistics & numerical data
  • Survival Rate
  • Tomography, X-Ray Computed / statistics & numerical data
  • Treatment Outcome